(A). Cumulative prednisone intake among patients who received prednisone plus CAT who either failed and went on to receive rituximab (PRE-RITUXIMAB) or successfully remained on CAT only (CAT-only). Data graph and linear slope over 12 months (A), or the first 3 months only (B).</p
Background: Pemphigus is an autoimmune disease that is challenging to treat and has few available th...
Rituximab and intravenous immunoglobulin [IVIg] have recently emerged as effective treatments for pe...
International audienceImportance: Rituximab and short-term corticosteroid therapy are the criterion ...
BACKGROUND:Rituximab is a promising steroid sparing agent used in the treatment of moderate to sever...
IF 44.002International audienceBackground High doses of corticosteroids are considered the standard ...
Outcomes among pemphigus patients who went on to receive rituximab vs. those who stayed on conventio...
Median prednisone dose among RT patients in their pre and post rituximab phases, and CAT-only patien...
BACKGROUND: The treatment of pemphigus is still challenging and some patients with pemphigus are unr...
To evaluate the long-term outcomes of rituximab in the treatment of pemphigus and the influence of d...
Background: The systemic use of corticosteroid is the treatment of choice for patients with pemphigu...
Background: Pemphigus is an autoimmune disease that is challenging to treat and has few available th...
Rituximab and intravenous immunoglobulin [IVIg] have recently emerged as effective treatments for pe...
International audienceImportance: Rituximab and short-term corticosteroid therapy are the criterion ...
BACKGROUND:Rituximab is a promising steroid sparing agent used in the treatment of moderate to sever...
IF 44.002International audienceBackground High doses of corticosteroids are considered the standard ...
Outcomes among pemphigus patients who went on to receive rituximab vs. those who stayed on conventio...
Median prednisone dose among RT patients in their pre and post rituximab phases, and CAT-only patien...
BACKGROUND: The treatment of pemphigus is still challenging and some patients with pemphigus are unr...
To evaluate the long-term outcomes of rituximab in the treatment of pemphigus and the influence of d...
Background: The systemic use of corticosteroid is the treatment of choice for patients with pemphigu...
Background: Pemphigus is an autoimmune disease that is challenging to treat and has few available th...
Rituximab and intravenous immunoglobulin [IVIg] have recently emerged as effective treatments for pe...
International audienceImportance: Rituximab and short-term corticosteroid therapy are the criterion ...